Gideon Blumenthal was named vice president for Global Oncology Regulatory Affairs at Merck.
Eric B. Haura was named the associate center director of Clinical Science at Moffitt Cancer Center, and Nikhil Khushalani was named assistant center director of Clinical Research Review & Partnerships in a newly created role at Moffitt Cancer Center.
Robert Bona was named professor of medicine (hematology) and inaugural director of the Benign Hematology Program at Smilow Cancer Hospital. He will also join as Medical Director of the Hemophilia Treatment Center for the Pediatric Hematology & Oncology Program at Smilow Cancer Hospital.
Thomas Prebet was named leader of myeloid malignancies on the Disease Aligned Research Team, and Amer Zeidan was named director of the Hematology Early Therapeutics Program at Yale Cancer Center.
Stanley Hamilton, formerly of MD Anderson Cancer Center, was named chair of the Department of Pathology at City of Hope, and Alexey Danilov was named associate director of City of Hope's Toni Stephenson Lymphoma Center.
Italo Tempera was appointed associate professor in the Gene Expression & Regulation Program of The Wistar Institute Cancer Center.
Bin Tian was appointed professor at the The Wistar Institute Cancer Center.
Tsvi Gal has been appointed Head of Infrastructure of MSK.
Seattle Cancer Care Alliance opened an Acute Clinical Evaluation clinic. The three bed ACE clinic at SCCA's South Lake Union campus serves individuals receiving cancer care at SCCA who experience cancer- and treatment-related pain and symptoms that surpass their ability to manage at home.
Robert Peter Gale has won an award in the opinion/op-ed category from the American Society of Journalists and Authors Inc. for his series “Chernobyl, the HBO miniseries: Fact and Fiction” (The Cancer Letter, May 17-June 21, 2019).
